Noncompaction cardiomyopathy and heterotaxy syndrome by Martinez, Hugo R. et al.
AC
CE
PT
ED
 M
AN
US
CR
IPT
NONCOMPACTION CARDIOMYOPATHY AND HETEROTAXY SYNDROME 
Hugo R. Martinez1, Stephanie M. Ware1, 2, Marcus S. Schamberger1, John J. Parent1, 
1 Department of Pediatrics, Indiana University School of Medicine. 
Riley Hospital for Children at Indiana University Health 
705 Riley Hospital Drive, Riley Research 127 
Indianapolis, IN 46202 
2 Department of Medical and Molecular Genetics, Indiana University School of Medicine. 
Riley Hospital for Children at Indiana University Health 
705 Riley Hospital Drive, Riley Research 127 
Indianapolis, IN 46202 
Corresponding author: 
John J. Parent, MD, MCS 
Riley Hospital for Children at Indiana University Health 
705 Riley Hospital Drive, Riley Research 127 
Indianapolis, IN 46202 
jjparent@iu.edu 
(317) 274-2954 (phone) 
(317) 274-1241 (fax) 
The authors have no conflicts of interest to disclose. 
ACCEPTED MANUSCRIPT
_________________________________________________________________________________
 
This is the author's manuscript of the article published in final edited form as: 
Martinez, H. R., Ware, S. M., Schamberger, M. S., & Parent, J. J. (2017). Noncompaction cardiomyopathy and 
heterotaxy syndrome. Progress in Pediatric Cardiology. https://doi.org/10.1016/j.ppedcard.2017.06.007
AC
CE
PT
ED
 M
AN
US
CR
IPT
 
 
2 
ABSTRACT 
Left ventricular noncompaction cardiomyopathy (LVNC) is characterized by compact 
and trabecular layers of the left ventricular myocardium. This cardiomyopathy may 
occur with congenital heart disease (CHD). Single cases document co-occurrence of 
LVNC and heterotaxy, but no data exist regarding the prevalence of this association. 
This study sought to determine whether a non-random association of LVNC and 
heterotaxy exists by evaluating the prevalence of LVNC in patients with heterotaxy. 
In a retrospective review of the Indiana Network for Patient Care, we identified 172 
patients with heterotaxy (69 male, 103 female). Echocardiography and cardiac magnetic 
resonance imaging results were independently reviewed by two cardiologists to ensure 
reproducibility of LVNC. A total of 13/172 (7.5%) patients met imaging criteria for LVNC. 
The CHD identified in this subgroup included atrioventricular septal defects (11), 
dextrocardia (10), systemic and pulmonary venous return abnormalities (7), and 
transposition of the great arteries (5). From this subgroup, 61% (n=8) of the patients 
developed arrhythmias; and 61% (n=8) required medical management for chronic heart 
failure. 
This study indicates that LVNC has increased prevalence among patients with 
heterotaxy when compared to the general population (0.014-1.3%) suggesting possible 
common genetic mechanisms. Interestingly, mice with a loss of function of Scrib or 
Vangl2 genes showed abnormal compaction of the ventricles, anomalies in cardiac 
looping, and septation defects in previous studies. Recognition of the association 
between LVNC and heterotaxy is important for various reasons. First, the increased risk 
of arrhythmias demonstrated in our population. Secondly, theoretical risk of 
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thromboembolic events remains in any LVNC population. Finally, many patients with 
heterotaxy undergo cardiac surgery (corrective and palliative) and when this is 
associated with LVNC, patients should be presumed to incur a higher peri-operative 
morbidity based on previous studies. Further research will continue to determine long-
term and to corroborate genetic pathways. 
 
Key words: Left ventricular noncompaction; cardiomyopathy; heterotaxy syndrome; 
MHY7 variant. 
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INTRODUCTION: 
Left ventricular noncompaction (LVNC) is a clinically heterogeneous 1 currently 
classified as a primary genetic cardiomyopathy by the American Heart Association (1). It 
is characterized by a two-layered structure consisting of prominent trabeculations and 
inter-trabecular recesses (2-4). The mechanistic basis for this cardiomyopathy remains 
controversial but it is thought to be secondary to an early fetal arrest of myocardial 
development with lack of compaction of the myocardial meshwork. (2, 3, 5-7). Based on 
the morphologic appearance of the myocardium, diagnostic criteria have been 
generated from different imaging modalities (8-12). The prevalence of LVNC is rather 
difficult to accurately obtain however some studies estimate it at about 0.014-1.3% in 
the general population (3, 7, 8, 13-15); however, this is probably an underestimate, 
since improved echocardiographic image quality and increasing awareness of LVNC 
has led to enhanced recognition. LVNC has been associated with different modes of 
inheritance including: X-linked, autosomal recessive, autosomal dominant, 
mitochondrial (12, 16). This cardiomyopathy has also been associated with several 
genetic syndromes, inborn errors of metabolism, and mitochondrial disorders (1). In 
addition, single genetic causes of LVNC have been associated to genes encoding 
sarcomeric and cytoskeletal proteins, and genes implicated in cardiac morphogenesis, 
such as DTNA, LDB3, MYH7, MYBPC3, ACTC1, NNT, among others (2, 16-19). 
Corroboration of LVNC in association with various forms of congenital heart disease 
(CHD) has been documented; some of these forms include but are not limited to 
stenotic lesions of the left ventricular outflow tract, Ebstein’s anomaly, septation defects 
and tetralogy of Fallot (7, 20, 21).  
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Heterotaxy is a heterogeneous syndrome where the internal thoraco-abdominal organs 
demonstrate abnormal arrangement across the left-right axis of the body (20). 
Cardiovascular malformations are commonly encountered in this condition due to 
abnormal heart looping during development (22, 23). The prevalence of heterotaxy in 
the general population has been reported as approximately 1 in 10,000 individuals (24). 
Heterotaxy has the highest relative recurrence risk amongst congenital heart defects, 
indicating a strong genetic basis (18, 20). Mutations in ZIC3 cause the X-linked form of 
heterotaxy (18, 25-28). In addition, mutations in genes important for cilia function 
underlie a subset of heterotaxy cases, often autosomal recessive in nature and 
overlapping with primary ciliary dyskinesia (29, 30). However, despite a good 
understanding of left-right development from animal models, in the majority of patients a 
genetic cause for heterotaxy is not well established (17, 31, 32). From the clinical 
perspective, heterotaxy syndrome has been associated with increased postoperative 
mortality and morbidity in patients undergoing cardiac surgical procedures (20, 24, 29, 
33). Single cases have documented co-occurrence of LVNC and heterotaxy syndrome, 
but no data exist on the prevalence of this association (34). In this study, we sought to 
determine whether a non-random association of LVNC and heterotaxy exists by 
evaluating the prevalence of LVNC in patients with heterotaxy and CHD. 
 
METHODS 
The Institutional Review Board at Indiana University Health approved the project. For 
the purposes of this study, we performed a retrospective chart review of medical 
records to identify patients with situs abnormalities. This information was obtained from 
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the Indiana Network for Patient Care. By reviewing medical records, a total of 172 
individuals were identified with heterotaxy syndrome and concomitant congenital heart 
disease (69 male, 103 female). Echocardiography was obtained in all patients, 
additional cardiac magnetic resonance imaging (cMRI) was available in three patients 
who did not have good quality echocardiograms due to poor imaging windows; all the 
studies (at least three different echocardiograms per patient) were independently 
reviewed by two cardiologists with additional expertise in heart failure and 
cardiomyopathies to ensure reproducibility in the diagnosis of LVNC. The 
echocardiographic criteria for LVNC was defined as the presence of a two-layered 
myocardial structure (a compact epicardial layer and an endocardial layer consisting of 
a prominent trabecular meshwork and deep intertrabecular spaces) particularly towards 
the apex at the end of systole in a standard parasternal short axis view. A non-
compacted to a compacted layer ratio greater than 2:1 was determined to be diagnostic 
based on previous publications (8, 35). Patients who met this criteria also presented 
multiple recesses in the left ventricular walls that communicate with the ventricular 
cavity by 2D and color Doppler echocardiography. Diagnosis for LVNC by cMRI was 
based on long axis views at the end of diastole in which the non-compacted to 
compacted ratio measured greater than 2.3:1 at the end of diastole (9). 
Electrocardiograms, 24-hour Holter monitoring and telemetry reports were assessed to 
determine the prevalence and type of rhythm abnormalities. Heterotaxy was diagnosed 
when patients with congenital heart defect(s) had at least one additional visceral situs 
anomaly or evidence of isomerism.  
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RESULTS: 
We identified 172 patients with heterotaxy syndrome associated with congenital heart 
disease. After completing the evaluation of cardiac imaging in this cohort, we found 
thirteen patients (7.5%) who met non-invasive imaging criteria for LVNC (three patients 
were diagnosed by cMRI and ten of them by echocardiography). From these thirteen 
patients, only one had been previously identified to have LVNC, demonstrating that it 
was under-recognized initially. Demographics of this subgroup showed 70% White 
(n=9), 15% Asian (n=2), 15% African American (n=2). Cardiovascular malformations 
identified in the LVNC patients included but were not limited to atrioventricular septal 
defects (11), dextrocardia (10), systemic and pulmonary venous drainage abnormalities 
(7), and transposition of the great arteries (5). All the patients in this subgroup 
underwent surgical procedures to repair or palliate their congenital heart defects; a 
summary of the cardiac defects is presented on Table 1. Most patient were able to 
undergo surgical repair with biventricular physiology (n=7) 54%; some were palliated for 
the single ventricle anatomy (n=6) 38%; and (n=1) 8% died in the neonatal period with 
no opportunity to undergo any surgical intervention except for a pacemaker 
implantation. At birth, this patient presented with prominent noncompaction 
cardiomyopathy which manifested soon a full spectrum of comorbidities; including 
severe cardiac dysfunction, thromboembolic events and supraventricular tachycardia 
(Figure 1). From the electrophysiologic stand point, 61% (n=8) had abnormalities, 
including supraventricular tachyarrhythmias (n=5), congenital atrioventricular block 
requiring pacemaker implantation (n=2), and post-surgical atrioventricular block (n=1); 
these findings are summarized in Table 1. From the group of patients presenting with 
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heterotaxy and LVNC, subjects 1, 6, 8, 9, 10, 11, 12 and 13 (61%) have required long-
term (>6 months) medical therapy for myocardial dysfunction after their latest surgical or 
palliative procedure (Table 1). The presence of arterial and venous thromboembolic 
events was reviewed; when present, some these cases were related to the use of 
central venous catheters hence further statistical analyses were not performed. 
 
DISCUSSION 
This study reveals that LVNC has an increased prevalence among patients with 
heterotaxy (7.5%) when compared to the general population (0.014-1.3%)(3, 7, 8, 13-
15). In this retrospective review, we observed that patients with bilateral right-sidedness 
presented a more complex cardiovascular phenotype, Table 1. In fact, the only patient 
who died at a young age within this cohort, belonged to this subtype and passed away 
at age three weeks. Knowledge of the association of heterotaxy and LVNC is important 
for the awareness of clinical implications in the pre- and post-operative periods which 
may identify a population at increased risk for additional morbidity (20, 21). Although the 
percentage of patients requiring heart failure therapy is elevated in this group (n=8; 
61%), one may opine that the clinical interpretation is variable due to the difference in 
the anatomy of these patients, and the surgical techniques used to manage them. After 
data collection was extracted, we attempted to analyze patient re-hospitalization rate, 
length of stay, and thromboembolic episodes as specific predictors of morbidity and 
mortality in this population. The attempt to analyze these data was not feasible due to a 
small number of subjects in the cohort, the lack of a control group and unmeasured 
factors that differed between these patients. This study is also limited by collection of 
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data from a single institution. Some frequent postoperative comorbidities linked to 
heterotaxy syndrome include arrhythmias, prolonged pleural effusions and re-operation 
(22, 36, 37). Although LVNC and heterotaxy are recognized as disorders with a genetic 
etiology based on the heritability of their manifestations, potential genetic pathways 
responsible for their co-occurrence have not been investigated. Interestingly, mice with 
a loss of function of Scrib or Vangl2 genes show abnormal compaction of the ventricular 
walls, anomalies in cardiac looping and septation defects(17, 31). The Drosophila 
scribble gene regulates apical-basal polarity and is implicated in control of cellular 
architecture and cell growth control; mutations in mammalian Scrib (circletail; Crc 
mutant) also result in neural tube defects and body axis anomalies similar to those 
observed when the planar cell polarity (PCP) gene Vangl2 is disrupted in the loop-tail 
(Lp) mutant models; further studies have concluded that Scrib and Vangl2 are not only 
required for PCP signaling during early embryogenesis but also for cardiomyocyte 
organization in the primary heart tube (31, 38, 39). The phenotype of these mice 
suggest that shared characteristics of a primitive myocardium and abnormal cellular 
polarity in these disorders may encompass common developmental and genetic 
mechanisms (31). Loss of Scrib prevents normal heart looping resulting in a clearly 
abnormal cardiac anatomy such as discordant ventriculo-arterial connections, double 
outlet right ventricle, atrioventricular septal defects and abnormal asymmetrical 
remodeling of the aortic arch arteries (31). Interestingly, a study from Phillips et al also 
demonstrated that the ventricles in Crc/Crc mutants remained with prominent trabeculae 
with deep intratrabecular recesses extending to the subepicardial region when 
compared with developmentally matched control embryos (31). These abnormalities in 
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the organization of the ventricular myocardium are similar to those described in the 
human cardiomyopathy, LVNC (35). 
 
CONCLUSION 
In conclusion, this study indicates that LVNC has an increased prevalence among 
patients with heterotaxy when compared to the general population suggesting possible 
common developmental and genetic mechanisms. Recognition of this association 
between LVNC and heterotaxy syndrome is important for clinicians for multiple reasons. 
First, the increased risk of arrhythmias demonstrated in our population. Secondly, 
theoretical risk of thromboembolic events remains in any LVNC population.  Finally, 
many patients with heterotaxy undergo cardiac surgery (corrective and palliative) and 
when this is also associated with LVNC these patients should be presumed to incur a 
higher peri-operative morbidity based on previous studies. Further research will 
continue to determine long-term outcome in this population and possibly to corroborate 
common genetic pathways. 
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Table 1. Summary of cardiovascular phenotype of the heterotaxy/LVNC group. 
 
SUBJECTS CHD diagnosis Initial surgical 
procedure 
Genetics analysis Current CV medical 
therapy 
EP 
 
disturbances 
Subject 1 Dex, AVSD, DORV, 
L-TGA, PS 
Modified BTS 
and PDA 
ligation. 
n/a Captopril, Atenolol, 
Digoxin, Sildenafil, 
Aspirin 
Postoperative 
junctional 
ectopic 
tachycardia 
Subject 2 Dex, AVSD, PAPVR, 
 
iIVC with Azy cont, 
LSVC 
AV canal repair 1.17-megabase 
duplication at 
13q31.1 identified by 
CGH. 
None Atrial ectopic 
tachycardia, 
complete AV 
block 
Subject 3 Dex, uAVSD, AS, 
PAPVR, LSVC 
DKS + 
modified BTS 
n/a Aspirin Complete AV 
block 
Subject 4 Levocardia, 
uAVSD, TAPVR, 
iIVC with Azy cont 
AV canal repair n/a None Atrial ectopic 
tachycardia 
Subject 5 Levocardia, AVSD, 
CoA, iIVC with Azy 
cont 
CoA repair 1.19-megabase 
deletion   at   1q21.1 
identified by CGH. 
None Postoperative 
junctional 
ectopic 
tachycardia 
Subject 6 Levocardia, 
uAVSD, iIVC with 
uAVSD 596.05-kb deletion at 
3q25 identified by 
CGH. 
Losartan None 
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 Azy cont, LSVC, 
PAPVR 
    
Subject 7 Dex, L-TGA, VSD, 
PS 
None n/a None None 
Subject 8 Dex, L-TGA, ASD, 
VSD, PS, PAPVR 
Double switch, 
PAPVR repair 
n/a Digoxin, Metoprolol Atrial flutter 
Subject 9 Dex, uAVSD Glenn 
procedure 
n/a Carvedilol Atrial ectopic 
tachycardia 
Subject 10 Dex, uAVSD, iIVC 
 
with Azy cont 
AV canal repair n/a Carvedilol None 
Subject 11 Dex, AVSD, DORV, 
LSVC, TAPVR 
Pacemaker 
implantation 
Normal CMA, 4 VUS 
from the heterotaxy 
gene panel by 
GeneDx® 
Milrinone Congenital 
compete AV 
block 
Subject 12 Dex, L-TGA, PS, 
 
uAVC, Ebstein’s 
anomaly 
Modified BTS Normal 22q FISH 
analysis 
Aspirin,  
Captopril, 
Coumadin, 
Furosemide 
None 
Subject 13 Dex, D-TGA, PS, 
uAVSD 
DKS +    
modified BTS 
n/a Digoxin, Lisinopril None 
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This table is assorted by subject number and it describes the cardiac phenotype in 
these patients, their initial surgical procedure, the post-operative medical regimen, 
and their genetic analysis when available.  
 
(AS) aortic valve stenosis; (ASD) atrial septal defect; (AV) atrioventricular; (AVSD) 
atrioventricular septal defect; (Azy cont) azygous vein continuation to the superior vena 
cava; (BTS) Blalock-Taussig shunt; (CGH) comparative genomic  hybridization; (CMA) 
chromosomal microarray; (CoA) coarctation of the aorta; (CTJ) cervicothoracic junction; 
(CV) cardiovascular; (DD) developmental delay; (Dex) dextrocardia; (DKS) Damus-
Kaye-Stansel procedure;  (DORV) double outlet right ventricle; (D-TGA) D-
transposition of the great arteries; (EP)  electrophysiological; (FISH) fluorescent in situ 
hybridization; (iIVC) interrupted inferior vena cava; (LSVC) left superior vena cava; (L-
TGA) L-transposition of the great arteries; (PAPVR) partial anomalous pulmonary 
venous return; (PDA) patent ductus arteriosus; (PS) pulmonary valve stenosis; (TAPVR) 
total anomalous pulmonary venous return; (uAVSD) unbalanced atrioventricular septal 
defect; (VSD) ventricular septal defect; (VUS) variant of unknown significance. 
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 Figure 1. Echocardiographic imaging of LVNC in the setting of heterotaxy syndrome. 
Echocardiography shows from a subcostal 4-chamber view, a patient with dextroversion, an 
unbalanced atrioventricular septal defect, and LVNC characterized by a prominent myocardial 
trabeculations and deep intertrabecular recesses.  
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Highlights 
 LVNC has increased prevalence among patients with heterotaxy when compared to the 
general population.  
 These disorders may encompass common developmental and genetic mechanisms.  
 Co-occurrence of LVNC and heterotaxy is clinically relevant and should be presumed to 
incur a higher peri-operative morbidity.  
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